A new recombinant fibrinolytic and antithrombotic agent with higher fibrin affinity – a staphylokinase variant. An in-vivo study - Szemraj, J; Stankiewicz, A; Rozmyslowicz-Szerminska, W (Thromb Haemost, 2007)